Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: A placebo controlled crossover study

Psychopharmacology

Volumn 231, Issue 14, 2014, Pages 2785-2798

  Leufkens, T R M ^a   Ramaekers, J G ^b   De Weerd, A W ^c   Riedel, W J ^b   Vermeeren, A ^b  

^a PHILIPS RESEARCH LABORATORIES   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Hypnotics; Insomnia; On the road driving; Residual effects; Zopiclone

Indexed keywords

FLURAZEPAM; LORAZEPAM; LORMETAZEPAM; MIDAZOLAM; NITRAZEPAM; OXAZEPAM; PLACEBO; TEMAZEPAM; ZOPICLONE; AZABICYCLO DERIVATIVE; HYPNOTIC SEDATIVE AGENT; PIPERAZINE DERIVATIVE;

ADULT; AGED; ALERTNESS; ARTICLE; BEDTIME DOSAGE; CAR DRIVING; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRIVING ABILITY; DRUG BLOOD LEVEL; DRUG TOLERANCE; FEMALE; HIGHWAY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHARMACOLOGICAL PARAMETERS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RESIDUAL DRUG EFFECT; RESPONSE TIME; SINGLE DRUG DOSE; SLEEP QUALITY; SLEEP TIME; TASK PERFORMANCE; CASE CONTROL STUDY; CONTROLLED CLINICAL TRIAL; ORAL DRUG ADMINISTRATION; SLEEP INITIATION AND MAINTENANCE DISORDERS;

ADMINISTRATION, ORAL; ADULT; AGED; AUTOMOBILE DRIVING; AZABICYCLO COMPOUNDS; CASE-CONTROL STUDIES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PIPERAZINES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84903642860     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3447-z     Document Type: Article

References (49)

1. Akerstedt T, Gillberg M (1990) Subjective and objective sleepiness in the active individual. Int J Neurosci 52:29-37
2. Association AP (1994) DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric, Washington DC
3. Barbone F, McMahon AD, Davey PG et al (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352:1331-1336
4. Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
5. Bocca ML, Sullivan M, Lelong-Boulouard V et al (2011) Zolpidem and zopiclone impair similarly monotonous driving performance after single nighttime intake in aged subjects. Psychopharmacol (Berl) 214:699-706
6. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211-218
7. Bosker WM, Kuypers KPC, Conen S et al (2012) MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid. Psychopharmacol (Berl) 222:367-376
8. Brookhuis KA, De Waard D, Mulder LJ (1994) Measuring driving performance by car-following in traffic. Ergonomics 37:427-434
9. Buysse DJ, Reynolds CF 3rd, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213
10. Curran HV, Collins R, Fletcher S et al (2003) Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med 33:1223-1237
11. Derogatis LR (1983) The SCL-90-R: administration, scoring and procedures manual II. Baltimore Clinical Psychometric Research, Baltimore
12. Dinges DF, Powell JW (1985) Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods Instrum Comput 17:652-655
13. Drake CL, Roehrs T, Roth T (2003) Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety 18:163-76
14. Gillin JC, Spinweber CL, Johnson LC (1989) Rebound insomnia: a critical review. J Clin Psychopharmacol 9:161-171
15. Glass J, Lanctot KL, Herrmann N et al (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Br Med J 331:1169-1175
16. Hemmelgarn B, Suissa S, Huang A et al (1997) Benzodiazepine use and the risk of motor vehicle crash in the elderly. J Am Med Assoc 278:27-31
17. Howard ME, Jackson ML, Kennedy GA et al (2007) The interactive effects of extended wakefulness and low-dose alcohol on simulated driving and vigilance. Sleep 30:1334-1340
18. Iber C, Ancoli-Israel S, Chesson A, Quan SF (2007) The AASM manual for the scoring of sleep ans associated events: rules, terminology and technical specifications. AASM, Westchester, Ill
19. Jex HR, McDonnell JD, Phatak A V (1966) A "critical" tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contract Rep NASA CR 1-105
20. Jongen S, Vuurman E, Ramaekers JG, Vermeeren A (2014) Alcohol calibration of tests measuring skills related to car driving. Psychopharmacology. doi: 10.1007/s00213-013-3408-y
21. Kales A, Manfredi RL, Vgontzas AN et al (1990) Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clin Pharmacol Ther 49:468-476
22. Lader M (1997) Zopiclone: is there any dependence and abuse potential? J Neurol 244:S18-S22
23. Leufkens TRM, Vermeeren A (2009) Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo. J Clin Psychopharmacol 29:432-438
24. Leufkens TRM, Vermeeren A (2014) Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and gender effects in four placebo controlled studies. Clin Ther 36:141-150
25. Leufkens TRM, Lund JS, Vermeeren A (2009) Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. J Sleep Res 18:387-396
26. Leufkens TRM, Ramaekers JG, de Weerd AW, Riedel WJ, Vermeeren A (2014) On-the-road driving performance and driving related skills in older untreated insomnia patients and chronic users of hypnotics. Psychopharmacology. doi: 10.1007/s00213-014-3455-z
27. Lim J, Dinges DF (2008) Sleep deprivation and vigilant attention. Ann N Y Acad Sci 1129:305-322
28. Logan GD, Cowan WB, Davis KA (1984) On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10:276-291
29. Louwerens JW, Gloerich ABM, de Vries G et al (1987) The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. Alcohol Drugs Traffic Saf T86:183-186
30. Moskowitz H (1973) Proceedings: psychological tests and drugs. Pharmakopsychiatr Neuropsychopharmakol 6:114-126
31. Mulder-Hajonides van der Meulen WREH (1981) Measurement of subjective sleep quality. Elsevier, Amsterdam
32. Neutel I (1998) Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharm 13:S115-S123
33. O'Hanlon JF (1984) Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 18:121s-129s
34. Pétursson H (1994) The benzodiazepine withdrawal syndrome. Addiction 89:1455-1459
35. Ramaekers JG (2011) Effects of medicinal drugs on actual and simulated driving. Deliverable 1.2.2., 2011. DRUID (Driving under the Influence of Drugs, Alcohol and Medicines). 6th Framework programme. Available via http://www.druid-project.eu/. Accessed 5 Dec 2013
36. Ramaekers JG, O'Hanlon JF (1994) Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol 47:261-266
37. Rey A (1964) L'examen clinique en psychologie. Presses Universitaires de France, Paris
38. Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315-325
39. Spielberger CD, Gorsuch RL, Lushene RE et al (1983) Manual for the State-Trait Anxiety Inventory (Form Y). Consulting Psychologists, Palo Alto
40. Staner L, Ertlé S, Boeijinga P et al (2005) Next day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacol (Berl) 181:790-798
41. Van Diest R, Milius H, Markusse R, Snel J (1989) The Sleep-Wake Experience List. Tijdschr Soc Gezondheidsz 67:343-347
42. Vermeeren A (2004) Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 18:297-328
43. Vermeeren A, O'Hanlon JF, Declerck AC, Kho L (1995) Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Theriol 21:47-64
44. Vermeeren A, Danjou PE, O'Hanlon JF (1998) Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol 13:S98-S107
45. Vermeeren A, Ramaekers JG, O'Hanlon JF (2002a) Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. J Psychopharmacol 16:57-64
46. Vermeeren A, Riedel WJ, van Boxtel MP et al (2002b) Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 25:224-231
47. Verster JC, Volkerts ER, Schreuder AH et al (2002) Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance. J Clin Psychopharmacol 22:576-583
48. Volkerts ER, Louwerens JW, Gloerich ABM, Brookhuis KJ, O'Hanlon JF (1984) Zopiclone's residual effect upon actual driving performance versus those of nitrazepam and flunitrazepam. Tech Rep VK-84-10. Traffic Research Centre, University of Groningen
49. Zijlstra FRH (1993) Efficiency in work behavior. A design approach for modern tools. Delft University of Technology